Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | -4.59% |
|
-18.11% | +6.67% |
06-20 | Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14% | MT |
05-09 | Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.67% | 24.22M | |
-4.12% | 184B | |
-3.00% | 103B | |
-4.62% | 67.59B | |
+15.60% | 46.93B | |
-9.43% | 43.87B | |
+8.28% | 41.2B | |
+17.38% | 30.47B | |
+13.59% | 24.16B | |
-7.22% | 23.57B |
- Stock Market
- Equities
- FEMY Stock
- News Femasys Inc.
- Femasys Gets License to Sell Products Directly in Canada